Screening Center Chooses Tecan for Reliability and Support
News Jun 11, 2010
The University of Chicago’s Cellular Screening Center (CSC) is using Tecan’s Freedom EVO® workstations to provide high throughput cell screening services to the University of Chicago, the University of Illinois at Chicago and Northwestern University.
Sam Bettis, Technical Director at the CSC, explained: “We are a service laboratory, performing various high throughput analysis projects, including whole genome siRNA screening and small molecule screening. When designing the laboratory, we chose the Freedom EVO platforms for their reliability and precision, as well as Tecan’s excellent customer service. Our laboratory can’t afford any downtime, so services like after-care support and annual service contracts are very important.”
“We have a complex set-up, and Tecan has helped us with software-related tasks, including integration of a microplate heat sealer and software upgrades. Tecan always responds to our needs very quickly, and we have a fantastic service engineer located here in Chicago. Everybody at Tecan – from sales to service – has been excellent, and there have been few issues. We are very happy with our Tecan workstations, and I have recommended them to several other laboratories.”
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.